-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CT-996 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CT-996 in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CT-996 in Type 2 Diabetes Drug Details: CT-996 (RG6652) is under...
-
Product Insights
Sarcopenia – Drugs In Development, 2023
Global Markets Direct’s, ‘Sarcopenia - Drugs In Development, 2023’, provides an overview of the Sarcopenia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Sarcopenia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Liver Cirrhosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Liver Cirrhosis - Drugs In Development, 2023’, provides an overview of the Liver Cirrhosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Liver Cirrhosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Post Partum Depression (Maternal Depression / Postnatal Depression) – Drugs In Development, 2023
Global Markets Direct’s, ‘Post Partum Depression (Maternal Depression / Postnatal Depression) - Drugs In Development, 2023’, provides an overview of the Post Partum Depression (Maternal Depression / Postnatal Depression) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Post Partum Depression (Maternal Depression / Postnatal Depression), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the...
-
Product Insights
Premature Labor (Tocolysis) – Drugs In Development, 2023
Global Markets Direct’s, ‘Premature Labor (Tocolysis) - Drugs In Development, 2023’, provides an overview of the Premature Labor (Tocolysis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Premature Labor (Tocolysis), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Hepatic Encephalopathy – Drugs In Development, 2023
Global Markets Direct’s, ‘Hepatic Encephalopathy - Drugs In Development, 2023’, provides an overview of the Hepatic Encephalopathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hepatic Encephalopathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Male Hypogonadism – Drugs In Development, 2023
Global Markets Direct’s, ‘Male Hypogonadism - Drugs In Development, 2023’, provides an overview of the Male Hypogonadism pipeline landscape. The report provides comprehensive information on the therapeutics under development for Male Hypogonadism, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DS-1055a in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DS-1055a in Gastric Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.DS-1055a in Gastric Cancer Drug Details:DS-1055a is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DS-1055a in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DS-1055a in Esophageal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.DS-1055a in Esophageal Cancer Drug Details:DS-1055a is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Influenza [Strains A + B] (Bivalent) Vaccine in Influenzavirus B Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Influenza [Strains A + B] (Bivalent) Vaccine in Influenzavirus B Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Influenza [Strains A + B] (Bivalent)...